Tests in Biological Technology

SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights

... to introduce a series of molecular diagnostics tests to the market, including the first of those based ... and fetal sex determination. The first of these tests - CFTR - is expected to launch this quarter or ... next quarter. The RHD and fetal sex determination tests are on target for launches thereafter. ...

Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress

... making to develop and commercialize additional tests to personalize the treatment of cancer. Since ... development and commercialization of additional tests to personalize the treatment of cancer; the ... levels of reimbursement for our existing tests and any ...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

... Program during the past quarter. Recent taste tests demonstrated that the Company's bitter blockers ... are encouraged by the data from our recent taste tests and the possibility of addressing the needs of ... enabled a significant reduction of sugar in taste tests with numerous product prototypes while ...

NeoGenomics Reports Second Quarter 2009 Results

... Q2 09 from $4.9 million in Q2 08. The number of tests increased by 43% in Q2 09, and average revenue ... Q1 09 driven by an 8% increase in the number of tests completed. The number of tests per requisition increased by 6.6% primarily due ...

FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business

... test positive for influenza A virus by commercial tests are infected with the pandemic flu virus. ... The FDA has not cleared or approved any tests for the identification of the 2009 H1N1 influenza ... worldwide. Focus Diagnostics develops innovative tests and products to assist physicians in diagnosing ...

Axial Biotech Enters Partnership with the University of Utah to Utilize the Utah Population Database to Develop Personalized Diagnostic Tests for Spine Disorders

... expand the development of additional personalized tests for scoliosis, degenerative disc disease and ... in an effort to develop diagnostic and prognostic tests that can enable the medical community to provide ... markers that can be used to develop diagnostic tests that allow for a more personalized and a more ...

Neogen Reports 16% Increase in Revenues

... increase in sales of each of Neogen's allergen tests is attributable to food producers increasing ... of Food Safety's oldest product line, its rapid tests to detect natural toxins in grain, also saw significant improvement for the year, as tests for aflatoxin and deoxynivalenol (DON) improved ...

Magellan Diagnostic Businesses to Feature Automated Systems and Diagnostic Tests at Clinical Lab Expo

... a variety of automated systems and diagnostic tests designed to help doctors make faster, ... microbial-detection system performs four tests on one automated platform: culture for blood, ... practical, cost-effective alternative to send-out tests that offers significant improvements over other ...

It's Not Just the Sun: deCODE Discovers Sequence Variants Affecting Susceptibility to Skin Cancer

... company developing drugs and DNA-based tests to improve the treatment, diagnosis and ... brought to market a growing range of DNA-based tests for gauging risk and empowering prevention of ... the genetic variants included in these tests and those linked to another twenty common ...

Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UK's Veterinary Laboratories Agency

... With the level of concordance between the two tests being above 97%, this confirmed the Enigma FL ... Enigma FL has been designed for easy operation. tests are provided in a single-use cartridge that can ... CEO of Enigma, stated: "The Enigma Diagnostics tests could be deployed for the related viral diseases, ...

BRAHMS, Cezanne and Lumiphore Announce Partnership for Diagnostic Tests

... technology into current and future diagnostic tests and the exclusive rights to use the technology in diagnostic tests for Down's Syndrome including Trisomy 21, 13 and ... in the reader technology of our diagnostic tests will provide multiple benefits for BRAHMS. Thus ...

BD and FIND Achieve Milestone in Global Battle Against MDR-TB

... Price reductions for liquid culture tests will accelerate access to improved TB diagnostics ... this month. The lower prices will enable more tests to be administered in 39 high-burden countries, ... US$ 61 million to extend access to these superior tests to an additional 11 high burden countries." ...

Successful Field-Trial Remediation of 1,2-DCA and VC Contaminated Groundwater in Northern Italy

... is proud to announce that laboratory and field tests recently conducted in Italy resulted in its ... described rigorous laboratory and field tests conducted to select and optimize an in situ ... of 1,2-DCA in the environment, initial laboratory tests evaluated various remedial technologies: two ...

Exiqon Diagnostics Partners With MedTrust Online to Promote KRAS Mutation Analysis and Other Innovative Molecular Oncology Diagnostic Services to Oncologists

... a competitive advantage: Sale of diagnostic tests (Exiqon Diagnostics), sale of innovative research ... treatment. By using molecular diagnostic tests that analyze the genetic profile of each ... tests. Exiqon already markets diagnostic tests that based on fresh tumor tissue enable doctors ...

Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting

... for one day developing commercial laboratory tests that will help physicians predict which patients ... Leumeta(TM) family of plasma-based molecular tests were the first available to doctors for directly ... with the goal of developing new laboratory tests for detecting prostate cancer in blood and urine. ...

Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting

... and pathology tests. All MammaPrint tests are conducted in Agendia's CLIA-accredited ... tumor gene expression profiling, the company's tests help physicians more accurately tailor cancer ... markets four products, with several new genomic tests under development. In addition, Agendia ...

deCODE Genotyping Laboratory Receives College of American Pathologists Accreditation

... scans and risk assessment diagnostic tests for several common diseases, has been accredited ... to market a growing range of DNA-based tests for gauging risk and empowering prevention of ... the genetic variants included in these tests and those linked to another twenty common ...

VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R)

... lab testing by offering thousands of medical lab tests and Value Panels affordably to consumers and ... facility that provides thousands of medical lab tests to consumers and employers in a professional, ... a variety of affordable and confidential lab tests to consumers and businesses including general ...

ASCP Joins ACLU Lawsuit Opposing Gene Patents

... limit the broad availability of diagnostic tests due to the simple fact that laboratory scientists are prohibited from performing genetic tests because of patent enforcement and the threat of ... inventions like new treatments, drugs, diagnostic tests or technology platforms," said Dr. McKenna. ...

deCODE genetics Announces First Quarter 2009 Financial Results

... for common diseases and apply those findings in tests and services that can improve the prevention ... deCODE uses in its own risk assessment tests and deCODEme service, are among the highest ... deCODE will receive royalties on sales of tests and services utilizing its markers. - ...

Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting

... of the NuroPro(R) AD and NuroPro(R) PD tests for Alzheimer's and Parkinson's disease at the ... of Neurology meeting in Seattle, WA. The NuroPro tests help clinicians distinguish patients with ... which develops and provides molecular diagnostic tests and instruments for genetic analysis, and Power3, ...

SENOMYX ANNOUNCES FIRST QUARTER 2009 FINANCIAL RESULTS

... enabled up to 50% reduction of sugar in taste tests with beverage, yogurt, cereal, cookie, ... in numerous food and beverage products. Taste tests have been initiated with samples that ... to increase their potency and efficacy, and taste tests have been initiated. - Cool Flavor Program: ...

Meso Scale Diagnostics' Point of Care Influenza Test Led to the First Identification of A(H1N1) Swine Flu Infection

... goal of advancing rapid point-of-care diagnostic tests for novel influenza viruses. Currently-available point of care influenza tests are designed to detect influenza A and B ... by BARDA and the CDC, for point-of-care tests with the ability to differentiate between common ...

GeneNews to conduct joint project funded by MYR 5 million grant from Malaysian government

... grant to develop blood-based diagnostic tests for liver cancer, Hepatitis B and nasopharyngeal ... focused on developing blood-based biomarker tests for the early detection of diseases and ... joint project to develop blood-based diagnostic tests for liver cancer, Hepatitis B and nasopharyngeal ...

Nasdaq Stays Suspension of Trading in deCODE Stock

... company developing drugs and DNA-based tests to improve the treatment, diagnosis and ... brought to market a growing range of DNA-based tests for gauging risk and empowering prevention of ... the genetic variants included in these tests and those linked to another twenty common ...

Cepheid Announces Symposium Speakers and Program Highlights for 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

... announced the menu of CE IVD molecular diagnostic tests to be featured in booth #611 on the exhibition ... Biology, Leeds 10:00 Do We Need Rapid tests to Detect Tuberculosis and Rifampicin ... a broad menu of on-demand molecular diagnostic tests designed to enhance patient management. The full ...

Cepheid Reports 2009 First Quarter Results

... economic uncertainty, sales for our Clinical tests continued to grow at a significant rate, running ... and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial ... for additional intellectual property licenses for tests and other products and the terms of such ...

deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes

... These markers can be incorporated into laboratory tests for assessing and managing individual risk of ... commitment to be a leading provider of genetic tests used routinely in personalizing disease ... differentiated, proprietary, and compelling tests that personalize cardiovascular ...

Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation

... strengthens Clarient's deep menu of molecular tests for breast cancer and will complement the ... what advantages it might have over competitive tests will help put this marker on a rapid commercial ... in identifying and developing new diagnostic tests or novel markers, the Company's ability to fund ...

Virco Lab, Inc. Enters Into Collaboration with SmartGene, Inc. Enhancing HIV Resistance Test Services for Laboratories and Physicians

... module. As a result, data from resistance tests can be stored indefinitely and accessed easily ... regimen, previously conducted resistance tests are often unavailable or are difficult to ... and treatment history but also any resistance tests that have been performed in the past.(2) ...

Atherotech to Exhibit its VAP(R) Cholesterol Test at Internal Medicine 2009 in Philadelphia

... adds new line of heart disease and diabetes tests to complement advanced cholesterol profile ... announced the addition of more than a dozen tests for patients at intermediate to high risk of ... glucose, vitamin D, fibrinogen and insulin. The tests can be ordered individually, or bundled as part ...

EnWave Announces Collaboration and Initial Testing Results with Danisco AS

... today announced the successful completion of tests using its recently developed powderREV technology ... and probiotics from the Danish group Danisco. The tests were conducted as the first phase of an Agreement ... bulk powder on a continuous basis. Preliminary tests on cultures were conducted at EnWave's Vancouver ...

Atherotech Unveils New Cardiometabolic Test Panels

... to be able to get these heart disease risk factor tests grouped together and not have to deal with ... Margolis. "They're also now offering specialized tests such as apoE genetic testing and NT-proBNP that ... glucose, vitamin D, fibrinogen and insulin. The tests can be ordered individually, or bundled as part ...

Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB)

... of infection. Due to their low accuracy, smear tests are followed up with culture tests, which offer ... diseases. FIND is dedicated to the development of tests that will have a measurable impact on TB ... of accurate and affordable diagnostic tests that can be used as near as possible to where ...

Norgen Biotek Corp. Announces OEM Manufacturing & Supply Agreement with Exiqon A/S

... a competitive advantage: sale of diagnostic tests (Exiqon Diagnostics), sale of innovative research ... treatment. By using molecular diagnostic tests that analyse the genetic profile of each ... tests. Exiqon already markets diagnostic tests that based on fresh tumor tissue enable doctors ...

New White Paper Examines Advanced Mycoplasma Tests - How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers

... free white paper, examines how PCR mycoplasma tests and analysis , deployed by a cutting-edge ... , a leader in biopharmaceutical and mycoplasma tests and services. "Whereas the traditional ... provide results, modern real-time PCR mycoplasma tests and analysis in an experienced testing laboratory ...

BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University

... Heart Study will be used to Discover New Blood tests for Heart Disease WALTHAM, Mass., March 12 ... partnership could ultimately lead to simple blood tests for heart disease that could help us identify ... ) is developing novel diagnostic tests based on biomarkers that are intended to provide ...

Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008

... New Molecular tests and Increasing Case Volumes Drive 78 Percent ... in identifying and developing new diagnostic tests or novel markers, the Company's ability to fund development of new diagnostic tests and novel markers and the amount of resources the ...

Agendia Presents Data Supporting MammaPrint's Predictive and Prognostic Power at 2009 St. Gallen Breast Cancer Conference

... and pathology tests. All MammaPrint tests are conducted in Agendia's CLIA-accredited ... tumor gene expression profiling, the company's tests aim to help physicians more accurately tailor ... markets four products, with several new genomic tests under development. In addition, ...

California Grants SeqWright License to Operate as a Clinical Laboratory

... Genotyping expertise in order to provide genetic tests to California residents and represents a ... is capable of performing validated genetic tests on individuals throughout the majority of the ... generally does not develop and market such tests internally and therefore, its role would be that ...